Sarepta Therapeutics, Inc. (SRPT) Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 Transcript
Corroborated by 2 sources from 2 publishers
globalcrime5h ago
TL;DR
Sarepta Therapeutics, Inc.
Sources
1
Seeking Alpha Market News
https://seekingalpha.com/article/4885847-sarepta-therapeutics-inc-srpt-discusses-preliminary-phase-i-ii-data-for-srpminus-1001-in?source=feed_all_articles
10h ago
2
Investing.com News
https://www.investing.com/news/analyst-ratings/bofa-reiterates-sarepta-therapeutics-stock-underperform-on-early-trial-data-93CH-4580721
7h ago
3
Seeking Alpha Market News
https://seekingalpha.com/article/4885845-sarepta-therapeutics-inc-srpt-discusses-preliminary-phase-i-ii-data-for-srpminus-1001-in?source=feed_all_articles
5h ago